Latest Conference Articles

CMSC 2022: What to Expect From the Annual Meeting

CMSC 2022: What to Expect From the Annual Meeting

May 25th 2022, 9:00pm

Consortium of Multiple Sclerosis Centers Annual Meeting

June Halper, MSN, APC-C, MSCN, FAAN, the chief executive officer of the Consortium of Multiple Sclerosis Centers, shared her perspective on what to expect from this year’s annual meeting, which takes place June 1-4, 2022, in National Harbor, Maryland.

Predicting Patient Response to MS Treatment Using Cognitive Outcome Measures: Ludwig Kappos, MD, FEAN, FAAN

Predicting Patient Response to MS Treatment Using Cognitive Outcome Measures: Ludwig Kappos, MD, FEAN, FAAN

May 2nd 2022, 2:00pm

American Academy of Neurology Annual Meeting

The professor of neurology at the University of Basel provided insight on a new methodology that allows depiction of patient profiles from baseline characteristics and their associations with individual outcomes. [WATCH NOW: 5 minutes]

Regenerative Medicine for Neurologic Injury and the Potential of SB623

Regenerative Medicine for Neurologic Injury and the Potential of SB623

April 29th 2022, 3:00pm

American Academy of Neurology Annual Meeting

Peter J. McAllister, MD, FAAN, medical director and chief medical officer, New England Center for Neurology and Headache, offered his insight into data from the phase 2 STEMTRA trial in TBI and the trends he’s observed in the field of regenerative medicine.

AAN Annual Meeting 2022: Top Expert Interviews

AAN Annual Meeting 2022: Top Expert Interviews

April 28th 2022, 1:00pm

American Academy of Neurology Annual Meeting

Expert clinicians offer their insight on the associations between stroke and COVID-19, treatment for traumatic brain injury, the latest on aducanumab, priorities for research in migraine, and more, from the 2022 American Academy of Neurology Annual Meeting.

NeuroVoices: Mark Lew, MD, on Exploring Reflex Tears as a Biomarker for Parkinson Disease

NeuroVoices: Mark Lew, MD, on Exploring Reflex Tears as a Biomarker for Parkinson Disease

April 27th 2022, 11:00am

American Academy of Neurology Annual Meeting

The director of the Division of Movement Disorders at the USC Keck School of Medicine discussed the phenomenon behind reflex tears and whether they can serve as a valuable biomarker for Parkinson disease.

Addition of Mechanical Thrombectomy Improves Odds of Good Outcome in Elderly Poststroke Patients

Addition of Mechanical Thrombectomy Improves Odds of Good Outcome in Elderly Poststroke Patients

April 26th 2022, 9:00pm

American Academy of Neurology Annual Meeting

Following respective improvements in odds of good and poor outcomes, investigators concluded that the addition of mechanical thrombectomy should be considered over best medical management practices alone.

Aligning Patient, Clinician, and Caregiver Goals in Alzheimer Disease: Sharon Cohen, MD, FRCPC

Aligning Patient, Clinician, and Caregiver Goals in Alzheimer Disease: Sharon Cohen, MD, FRCPC

April 26th 2022, 1:00pm

American Academy of Neurology Annual Meeting

The neurologist and assistant professor at the University of Toronto discussed why elevating the voices of patients and caregivers is important to understanding and treating an individual with Alzheimer disease. [WATCH TIME: 3 minutes]

Ozanimod Treatment Results in Higher Rates of No Evidence of Disease Activity vs Interferon ß-1a

Ozanimod Treatment Results in Higher Rates of No Evidence of Disease Activity vs Interferon ß-1a

April 25th 2022, 7:00pm

American Academy of Neurology Annual Meeting

After readjusting baseline to month 12, more patients with relapsing multiple sclerosis on continuous ozanimod achieved NEDA-3 and NEDA-4 status than those on interferon ß-1a.

Idiopathic Hypersomnia Demonstrates Moderate to Severe Impact on Quality of Life, Patient-Reported Outcomes

Idiopathic Hypersomnia Demonstrates Moderate to Severe Impact on Quality of Life, Patient-Reported Outcomes

April 25th 2022, 3:00pm

American Academy of Neurology Annual Meeting

Despite a low percentage of patients missing work time due to their condition, a higher percentage reported impairment while working, overall work impairment, and activity impairment.

Treatment Optimization in Epilepsy and the Need to Individualize the Approach

Treatment Optimization in Epilepsy and the Need to Individualize the Approach

April 24th 2022, 11:00pm

American Academy of Neurology Annual Meeting

Jacqueline A. French, MD, discussed the factors that influence the challenges in treatment selection in epilepsy, and how patient conversations and comprehension of heterogeneity can help in the treatment selection process.